CARM1 is required for proper control of proliferation and differentiation of pulmonary epithelial cells
Year: 2010
Type: article
Abstract: Coactivator-associated arginine methyltransferase I (CARM1; PRMT4) regulates gene expression by multiple mechanisms including methylation of histones and coactivation of steroid receptor transcription. Mice lacking CARM1 are small, fail to breathe and die shortly after birth, demonstrating the crucial role of CARM1 in development. In adults, CARM1 is overexpressed in human grade-III breast tumors and prostate adenocarcinomas, and knockdown of CARM1 inhibits proliferation of breast and prostate cancer cell lines. Based on these observations, we hypothesized that loss of CARM1 in mouse embryos would inhibit pulmonary cell proliferation, resulting in respiratory distress. By contrast, we report here that loss of CARM1 results in hyperproliferation of pulmonary epithelial cells during embryonic development. The lungs of newborn mice lacking CARM1 have substantially reduced airspace compared with their wild-type littermates. In the absence of CARM1, alveolar type II cells show increased proliferation. Electron microscopic analyses demonstrate that lungs from mice lacking CARM1 have immature alveolar type II cells and an absence of alveolar type I cells. Gene expression analysis reveals a dysregulation of cell cycle genes and markers of differentiation in the Carm1 knockout lung. Furthermore, there is an overlap in gene expression in the Carm1 knockout and the glucocorticoid receptor knockout lung, suggesting that hyperproliferation and lack of maturation of the alveolar cells are at least in part caused by attenuation of glucocorticoid-mediated signaling. These results demonstrate for the first time that CARM1 inhibits pulmonary cell proliferation and is required for proper differentiation of alveolar cells.
Source: Development
DOI: 10.1242/dev.037150
Authors: Karen B. O'Brien, Meritxell Alberich-Jordà, Neelu Yadav, Olivier Kocher, Annalisa DiRuscio, Alexander Ebralidze, Elena Levantini, Natasha J. L. Sng, Manoj Bhasin, Tyler Caron, Daehoon Kim, Ulrich Steidl, Gang Huang, Balázs Halmos, Scott J. Rodig, Mark T. Bedford, Daniel G. Tenen, Susumu Kobayashi
Institutions: Harvard University, Harvard Stem Cell Institute, University at Buffalo, State University of New York, Beth Israel Deaconess Medical Center, Brigham and Women's Hospital, The University of Texas MD Anderson Cancer Center, Albert Einstein College of Medicine, Yeshiva University, Cincinnati Children's Hospital Medical Center, Columbia University Irving Medical Center, Herbert Irving Comprehensive Cancer Center, National University of Singapore
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
Awards: G132912798, G1592235300, G256420901, Role of EGFR mutations and new therapeutics in lung cancer, G286522202, G3998179438, G458608165, Mechanisms and Prevention of Environmental Disease, Identification of Regulatory Elements of the Human C/EBPalpha Gene, G6840756229, G6991487918, G793629736, G8677339279
OpenAlex ID: W2056525001
